Derepression of hTERT gene expression promotes escape from oncogene-induced cellular senescence
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Significance: Normal cells respond to oncogenic signals by activating cellular senescence, a state of irreversible/permanent growth arrest that prevents cells from undergoing further cell divisions. Although this oncogene-induced senescence (OIS) is considered a critical tumor-suppressive mechanism, the irreversible nature of OIS remains controversial. In this study, we demonstrate that OIS is not always stable. After a prolonged period in senescence, cells can re-enter the cell-division cycle with epigenetic changes that facilitate cell transformation. Escape from OIS was promoted by derepression of hTERT gene expression, an enzyme that provides cellular immortality and is activated in >90% of human cancers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although the senescence cell-cycle arrest is generally irreversible, cell-cycle re-entry can occur under certain circumstances, particularly in tumor cells (Galanos et al., 2016; Milanovic et al., 2018; Patel et al., 2016; Saleh et al., 2019) (Figure 2).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Patel et al., 2016
In the citing paper
“Although the cell cycle arrest in cellular senescence is believed to be irreversible, studies have recently shown that senescent cells can under certain circumstances re-enter the cell cycle such as in tumor cells (Galanos et al., 2016; Patel et al., 2016; Milanovic et al., 2018; Saleh et al., 2019) or be reprogrammed into induced pluripotent stem cells (Banito and Gil, 2010; Lapasset et al., 2011”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Patel et al., 2016
In the citing paper
“recent studies have demonstrated that telomerase expression in cells arrested due to OIS is capable of resolving existing telomere damage, and prevents further telomere dysfunction in these cells.”
From Telomeres and cell senescence—size matters not (2017) · cites this paper as Patel et al., 2016
In the citing paper
“Therefore, telomerase alleviates telomere damage as a result of replication stress in pre-malignant cells, allowing these cells to escape senescence, and contribute to cancer progression (Meena et al., 2015, Patel et al., 2016).”
From Telomeres and cell senescence—size matters not (2017) · cites this paper as Patel et al., 2016
Citations
Cites
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 2×
“Oncogene-induced senescence (OIS) is a response of cells encountering strong oncogenic signals, such as those initiated by mutant and constitutively active H-Ras (5) or the downstream effector kinase B-Raf (6).”
BackgroundMAP kinase signalling pathways in cancer
Dhillon, A. S., Hagan, S., Rath, O., & Kolch, W. (2007) · Oncogene · doi:10.1038/sj.onc.1210421 · Cited by 2,995 · cited 1×
“Deregulation of the Ras–MAP kinase pathway, either because of aberrant activation of upstream receptor-mediated signaling cascades or as a consequence of mutations directly in Ras and downstream effector kinases, is observed in most human cancers (50).”
BackgroundA DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917 · cited 6×
“E5024–E5033 | PNAS | Published online August 8, 2016 www.pnas.org/cgi/doi/10.1073/pnas.1602379113 DDR, which ultimately leads to telomere dysfunction-induced cellular senescence (TDIS) (16, 17).”
BackgroundInfluentialCellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818 · cited 1×
“In mammals, a primary function of cellular senescence is to suppress cancer development; however, other roles for this stress response have also emerged in recent years (4).”
BackgroundRb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 1×
“These observations suggest that one function of SAHF formation is to repress expression of growth-promoting genes during cellular senescence (12, 13, 15).”
BackgroundBRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
The essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038 · cited 1×
“Cellular senescence is generally thought to be an irreversible proliferative arrest, activated in response to numerous cell intrinsic and extrinsic signals and stresses (3).”
BackgroundOncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986 · cited 2×
“The ensuing DNA damage response (DDR) triggers OIS, thereby arresting cells within a few cell-division cycles after oncogene expression (8, 9).”
BackgroundOncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821 · cited 2×
“The ensuing DNA damage response (DDR) triggers OIS, thereby arresting cells within a few cell-division cycles after oncogene expression (8, 9).”
BackgroundMultiple Ras-dependent phosphorylation pathways regulate Myc protein stability
Sears, R., Nuckolls, F., Haura, E., Taya, Y., Tamai, K., & Nevins, J. R. (2000) · Genes & Development · doi:10.1101/gad.836800 · Cited by 1,393
Herbig, U., Jobling, W. A., Chen, B. P. C., Chen, D. J., & Sedivy, J. M. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00256-4 · Cited by 1,344 · cited 6×
“E5024–E5033 | PNAS | Published online August 8, 2016 www.pnas.org/cgi/doi/10.1073/pnas.1602379113 DDR, which ultimately leads to telomere dysfunction-induced cellular senescence (TDIS) (16, 17).”
BackgroundSelf-citationMiller, A. J., & Mihm, M. C. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052166 · Cited by 1,339
Targeting RAS–ERK signalling in cancer: promises and challenges
Samatar, A. A., & Poulikakos, P. I. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4281 · Cited by 1,163 · cited 1×
“In addition, because Ras–MAP kinase signaling is essential for hTERT expression in cells that had escaped OIS, conventional inhibitors of this signaling pathway may even be effective in inhibiting telomerase activity in early transformed human cancer cells, as our data would suggest (51).”
ResultSenescence in tumours: evidence from mice and humans
Collado, M., & Serrano, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2772 · Cited by 1,124 · cited 1×
“We and others have demonstrated that the reasons for the inactive nature of certain human cancer precursor lesions is because cells within these lesions had undergone cellular senescence (1, 2).”
BackgroundInhibition of telomerase limits the growth of human cancer cells
Hahn, W. C., Stewart, S. A., Brooks, M. W., York, S. G., Eaton, E., Kurachi, A., Beijersbergen, R. L., Knoll, J. H. M., Meyerson, M., & Weinberg, R. A. (1999) · Nature Medicine · doi:10.1038/13495 · Cited by 1,030
Mammalian Telomeres Resemble Fragile Sites and Require TRF1 for Efficient Replication
Sfeir, A., Kosiyatrakul, S. T., Hockemeyer, D., MacRae, S. L., Karlseder, J., Schildkraut, C. L., & de Lange, T. (2009) · Cell · doi:10.1016/j.cell.2009.06.021 · Cited by 990 · cited 1×
“In fact, telomeres are particularly prone to DNA breakage because they resemble fragile sites (18, 19).”
BackgroundHewitt, G., Jurk, D., Marques, F. D. M., Correia-Melo, C., Hardy, T., Gackowska, A., Anderson, R., Taschuk, M., Mann, J., & Passos, J. F. (2012) · Nature Communications · doi:10.1038/ncomms1708 · Cited by 908 · cited 11×
“A critical question that remains unanswered, however, is whether telomeric DSBs, or dysfunctional telomeres, can be repaired by telomerase, even after they have activated a persistent DDR.”
BackgroundInfluentialDirect activation of TERT transcription by c-MYC
Wu, K.-J., Grandori, C., Amacker, M., Simon-Vermot, N., Polack, A., Lingner, J., & Dalla-Favera, R. (1999) · Nature Genetics · doi:10.1038/6010 · Cited by 893 · cited 1×
“c-Myc transactivates hTERT expression by binding to E-boxes in the promoter region of the hTERT gene (33, 34).”
BackgroundTelomeric DNA damage is irreparable and causes persistent DNA-damage-response activation
Fumagalli, M., Rossiello, F., Clerici, M., Barozzi, S., Cittaro, D., Kaplunov, J. M., Bucci, G., Dobreva, M., Matti, V., Beausejour, C. M., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2466 · Cited by 851 · cited 12×
“A critical question that remains unanswered, however, is whether telomeric DSBs, or dysfunctional telomeres, can be repaired by telomerase, even after they have activated a persistent DDR.”
InfluentialSelf-citationTelomeres and telomerase in cancer
Artandi, S. E., & DePinho, R. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp268 · Cited by 823 · cited 1×
“Consisting of two core components, a catalytic subunit hTERT and a template RNA component hTR, telomerase counteracts telomere shortening by adding de novo telomeric repeats to chromosomal ends (21).”
BackgroundTelomerase maintains telomere structure in normal human cells
Kenichi, M., Yu, E. Y., Shilagardi, K., Ben‐Porath, I., Currier, J. L., Metz, G. B., Brooks, M. W., Kaneko, S., Seishi, M., DeCaprio, J. A., et al. (2006) · Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University) · Cited by 738
Wang, J., Xie, L. Y., Allan, S., Beach, D., & Hannon, G. J. (1998) · Genes & Development · doi:10.1101/gad.12.12.1769 · Cited by 653 · cited 1×
“c-Myc transactivates hTERT expression by binding to E-boxes in the promoter region of the hTERT gene (33, 34).”
BackgroundThe transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer
Bell, R. J. A., Rube, H. T., Kreig, A., Mancini, A., Fouse, S. D., Nagarajan, R. P., Choi, S., Hong, C., He, D., Pekmezci, M., et al. (2015) · Science · doi:10.1126/science.aab0015 · Cited by 566
Ras Enhances Myc Protein Stability
Sears, R., Leone, G., DeGregori, J., & Nevins, J. R. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80308-1 · Cited by 460 · cited 1×
“Significantly, signaling through the Ras/B-Raf MAP kinase pathway increases c-Myc protein levels, not only by suppressing its degradation (35, 36), but also by promoting c-Myc gene expression (37).”
BackgroundDe Cecco, M., Criscione, S. W., Peckham, E. J., Hillenmeyer, S., Hamm, E. A., Manivannan, J., Peterson, A. L., Kreiling, J. A., Neretti, N., & Sedivy, J. M. (2013) · Aging Cell · doi:10.1111/acel.12047 · Cited by 459 · cited 1×
“These changes may be specific for oncogene-expressing cells, because derepression of hTERT transcription is not observed in cells that had undergone replicative senescence, even for prolonged periods (40).”
BackgroundHistological and biological evolution of human premalignant breast disease.
Allred, D. C., Mohsin, S. K., & Fuqua, S. A. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080047 · Cited by 416
Molecular dissection of formation of senescence-associated heterochromatin foci
Zhang, R., Chen, W., & Adams, P. D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02019-06 · Cited by 415 · cited 2×
“Initially identified by DAPI staining, SAHFs are highly condensed regions of individual chromosomes that are enriched in heterochromatin proteins (12, 13).”
BackgroundInterplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer
Di Micco, R., Sulli, G., Dobreva, M., Liontos, M., Botrugno, O. A., Gargiulo, G., dal Zuffo, R., Matti, V., d'Ario, G., Montani, E., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2170 · Cited by 382 · cited 1×
“Although previously thought to be structures exclusive to senescent cells, more recent studies have demonstrated that SAHFs are features of cells expressing oncogenes, regardless of whether they are proliferating or senescent (14).”
ResultMartínez, P., Thanasoula, M., Muñoz, P., Liao, C., Tejera, A., McNees, C., Flores, J. M., Fernández-Capetillo, O., Tarsounas, M., & Blasco, M. A. (2009) · Genes & Development · doi:10.1101/gad.543509 · Cited by 370 · cited 1×
“In fact, telomeres are particularly prone to DNA breakage because they resemble fragile sites (18, 19).”
BackgroundUnderstanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers
Kyo, S., Takakura, M., Fujiwara, T., & Inoue, M. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00878.x · Cited by 347 · cited 1×
“A number of transcription factors have been demonstrated to activate expression of hTERT mRNA in mammalian cells (30).”
BackgroundSignaling Networks That Link Cell Proliferation and Cell Fate
Sears, R. C., & Nevins, J. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100063200 · Cited by 336 · cited 2×
“Signaling through the H-Ras and B-Raf MAP kinase pathway can regulate c-Myc expression and protein stability, thereby promoting transactivation of a number of c-Myc–regulated genes (7).”
BackgroundDuctal Carcinoma In situ and the Emergence of Diversity during Breast Cancer Evolution
Allred, D. C., Wu, Y., Mao, S., Nagtegaal, I. D., Lee, S., Perou, C. M., Mohsin, S. K., O'Connell, P., Tsimelzon, A., & Medina, D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1127 · Cited by 285
Regulation of the human catalytic subunit of telomerase (hTERT)
Daniel, M., Peek, G. W., & Tollefsbol, T. O. (2012) · Gene · doi:10.1016/j.gene.2012.01.095 · Cited by 266
Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis
Vredeveld, L. C. W., Possik, P. A., Smit, M. A., Meissl, K., Michaloglou, C., Horlings, H. M., Ajouaou, A., Kortman, P. C., Dankort, D., McMahon, M., et al. (2012) · Genes & Development · doi:10.1101/gad.187252.112 · Cited by 262
Loss of linker histone H1 in cellular senescence
Funayama, R., Saito, M., Tanobe, H., & Ishikawa, F. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200604005 · Cited by 241 · cited 2×
“Initially identified by DAPI staining, SAHFs are highly condensed regions of individual chromosomes that are enriched in heterochromatin proteins (12, 13).”
BackgroundTERT promoter mutations in cancer development
Heidenreich, B., Rachakonda, P. S., Hemminki, K., & Kumar, R. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.11.005 · Cited by 238 · cited 2×
“However, because most cancers reactivate hTERT gene expression independent of promoter mutations (26), other and currently unknown mechanisms must exist that promote epigenetic changes and create an active chromatin state at the hTERT promoter during cancer development in humans.”
BackgroundSuram, A., Kaplunov, J., Patel, P. L., Ruan, H., Cerutti, A., Boccardi, V., Fumagalli, M., Di Micco, R., Mirani, N., Gurung, R. L., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.132 · Cited by 227 · cited 10×
“Consistent with our published data demonstrating that oncogenes cause telomeric replication defects and telomere dysfunction in normal somatic human cells (1), inhibition of telomerase activity in cells that had escaped H-Ras– and B-Raf–induced senescence caused rapid and stochastic telomere attrition that was even mo…”
BackgroundMethodResultSelf-citationStern, J. L., Theodorescu, D., Vogelstein, B., Papadopoulos, N., & Cech, T. R. (2015) · Genes & Development · doi:10.1101/gad.269498.115 · Cited by 189 · cited 2×
“Recently discovered hTERT promoter mutations in human cancer cells have been demonstrated to alter the local epigenetic landscape from a repressive state to open and transcriptionally active chromatin, providing a mechanism that may act as an epigenetic switch at the hTERT promoter (25).”
BackgroundStable Cellular Senescence Is Associated with Persistent DDR Activation
Fumagalli, M., Rossiello, F., Mondello, C., & d’Adda di Fagagna, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110969 · Cited by 183 · cited 1×
“Furthermore, it is unclear whether senescence induced by these or other oncogenes is inherently less stable compared with, for example, replicative senescence in which cells can remain stably arrested for at least 3 y (32).”
BackgroundAge‐associated increase in heterochromatic marks in murine and primate tissues
Kreiling, J. A., Tamamori‐Adachi, M., Sexton, A. N., Jeyapalan, J. C., Munoz‐Najar, U., Peterson, A. L., Manivannan, J., Rogers, E. S., Pchelintsev, N. A., Adams, P. D., et al. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2010.00666.x · Cited by 152 · cited 2×
“In line with this interpretation are our observations that hTERT-positive cells in intermediate- and late-stage human breast and melanocytic skin cancers also display high levels of HP1β, a heterochromatin protein whose abundance peaks in senescent cells (31).”
ResultRegulation of c-myc expression by Ras/Raf signalling
Kerkhoff, E., Houben, R., Löffler, S., Troppmair, J., Lee, J., & Rapp, U. R. (1998) · Oncogene · doi:10.1038/sj.onc.1201520 · Cited by 144 · cited 1×
“Significantly, signaling through the Ras/B-Raf MAP kinase pathway increases c-Myc protein levels, not only by suppressing its degradation (35, 36), but also by promoting c-Myc gene expression (37).”
BackgroundATM and ATR Signaling Regulate the Recruitment of Human Telomerase to Telomeres
Tong, A. S., Stern, J. L., Sfeir, A., Kartawinata, M., de Lange, T., Zhu, X.-D., & Bryan, T. M. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.041 · Cited by 142 · cited 1×
“Recent studies that demonstrate a requirement for DNA damage checkpoint kinases ATM and ATR for extending telomeric repeats after DSB formation and DNA replication fork stalling, respectively, support our conclusions that telomerase is also recruited to telomeric lesions after DNA damage checkpoint kinases become acti…”
BackgroundAtkinson, S. P., Hoare, S. F., Glasspool, R. M., & Keith, W. N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1715 · Cited by 112 · cited 1×
“In somatic human cells, however, transcription of telomerase is suppressed because of a repressive chromatin state at the hTERT promoter (22, 23).”
BackgroundATM Kinase Is Required for Telomere Elongation in Mouse and Human Cells
Lee, S. S., Bohrson, C., Pike, A. M., Wheelan, S. J., & Greider, C. W. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.035 · Cited by 106 · cited 1×
“Recent studies that demonstrate a requirement for DNA damage checkpoint kinases ATM and ATR for extending telomeric repeats after DSB formation and DNA replication fork stalling, respectively, support our conclusions that telomerase is also recruited to telomeric lesions after DNA damage checkpoint kinases become acti…”
BackgroundHuman telomerase activity regulation
Wojtyla, A., Machnik, M., & Rubiś, B. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0439-x · Cited by 104 · cited 1×
“For example, although hTERT is regulated primarily at the transcriptional level, its enzymatic activity can also be modulated by posttranslational modifications or holoenzyme assembly, among other mechanisms (29).”
BackgroundChromatin and epigenetic regulation of the telomerase reverse transcriptase gene
Zhu, J., Zhao, Y., & Wang, S. (2010) · Protein & Cell · doi:10.1007/s13238-010-0014-1 · Cited by 81 · cited 4×
“To escape OIS, cells had to overcome the barriers that suppress telomerase expression, including epigenetic silencing of the hTERT promoter and a tight regulation of transcription factors that promote hTERT gene expression (23, 24).”
BackgroundInfluentialTelomerase Maintains Telomere Structure in Normal Human Cells
Masutomi, K., Yu, E. Y., Khurts, S., Ben-Porath, I., Currier, J. L., Metz, G. B., Brooks, M. W., Kaneko, S., Murakami, S., DeCaprio, J. A., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00550-6 · Cited by 70 · cited 1×
“An increase in dysfunctional telomeres following inhibition of hTERT is consistent with a proposed role of hTERT in facilitating telomere replication during the S-phase of the cell cycle in normal human somatic cells (28).”
BackgroundCorpet, A., & Stucki, M. (2014) · Chromosoma · doi:10.1007/s00412-014-0469-6 · Cited by 63 · cited 1×
“Chromatin changes associated with cellular senescence are thought to repress expression of growth-promoting genes, while derepressing genes required for senescence induction, maintenance, and cell survival (39).”
BackgroundNelson, D. M., McBryan, T., Jeyapalan, J. C., Sedivy, J. M., & Adams, P. D. (2014) · AGE · doi:10.1007/s11357-014-9637-0 · Cited by 63
The replicometer is broken: telomeres activate cellular senescence in response to genotoxic stresses
Suram, A., & Herbig, U. (2014) · Aging Cell · doi:10.1111/acel.12246 · Cited by 60 · cited 1×
“Importantly, the generation of such dysfunctional telomeres is critical to stabilize an otherwise transient proliferative arrest in H-Ras– and B-Raf–expressing human somatic cells (1, 20).”
BackgroundSelf-citationRegulation of telomere addition at DNA double-strand breaks
Ribeyre, C., & Shore, D. (2013) · Chromosoma · doi:10.1007/s00412-013-0404-2 · Cited by 41 · cited 1×
“In addition to its ability to suppress telomere erosion by extending short telomeres, telomerase can synthesize new telomeric sequences at DSBs by a process termed chromosome healing (41).”
BackgroundNon-random spatial association of melanoma and naevi - a morphometric analysis
Smolle, J., Kaddu, S., & Kerl, H. (1999) · Melanoma Research · doi:10.1097/00008390-199908000-00011 · Cited by 27
Cited by
Cellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225
Self-citationMechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype
Kumari, R., & Jat, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.645593 · Cited by 1,622
Immunosenescence: molecular mechanisms and diseases
Liu, Z., Liang, Q., Ren, Y., Guo, C., Ge, X., Wang, L., Cheng, Q., Luo, P., Zhang, Y., & Han, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01451-2 · Cited by 960
Exploiting senescence for the treatment of cancer
Wang, L., Lankhorst, L., & Bernards, R. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00450-9 · Cited by 867
Senescence and cancer — role and therapeutic opportunities
Schmitt, C. A., Wang, B., & Demaria, M. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00668-4 · Cited by 794
Metadata
- Authors
- Patel, P. L., Suram, A., Mirani, N., Bischof, O., & Herbig, U.
- Affiliations
- Rutgers Health (US)
- Inserm (FR)
- Rutgers, The State University of New Jersey (US)
- Corresponding author
- Herbig, Utz
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2016-08-08
- Volume
- 113
- Issue
- 34
- Pages
- E5024-33
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC5003242
- OpenAlex
- W2508099675
- Cited by
- 142
- References
- 51
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 13 · 2023: 18 · 2022: 23 · 2021: 20 · 2020: 14 · 2019: 13 · 2018: 11 · 2017: 8 · 2016: 2
- FWCI
- 9.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by-nc-nd)
- Funders
- HHS | NIH | National Cancer Institute (R01CA136533, R01CA184572)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- oncogene-induced senescence, senescence escape, hTERT, telomerase reactivation, telomere dysfunction, DNA damage response, c-Myc, H-Ras, BRAF, MAPK signaling, replication stress, tumor progression, skin cancer, breast tissue
- MeSH terms
- Breast Neoplasms, Cell Line, Cell Survival, Epithelial Cells, Female, Fibroblasts, Humans, Male, Skin Neoplasms, Signal Transduction, Oncogene Protein p21(ras), Gene Expression Regulation, Neoplastic, Proto-Oncogene Proteins c-myc, Telomere, Cellular Senescence, Telomerase, Cell Line, Tumor, Proto-Oncogene Proteins B-raf, Telomere Homeostasis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.